View Item 

Show simple item record

The interaction between C 5a and both C 5a R and C 5 L 2 receptors is required for production of G ‐ CSF during acute inflammation
dc.contributor.authorBosmann, Markusen_US
dc.contributor.authorHaggadone, Mikel D.en_US
dc.contributor.authorZetoune, Firas S.en_US
dc.contributor.authorSarma, J. Vidyaen_US
dc.contributor.authorWard, Peter A.en_US
dc.date.accessioned2013-08-02T20:51:26Z
dc.date.available2014-09-02T14:12:53Zen_US
dc.date.issued2013-07en_US
dc.identifier.citationBosmann, Markus; Haggadone, Mikel D.; Zetoune, Firas S.; Sarma, J. Vidya; Ward, Peter A. (2013). "The interaction between C 5a and both C 5a R and C 5 L 2 receptors is required for production of G ‐ CSF during acute inflammation." European Journal of Immunology 43(7): 1907-1913. <http://hdl.handle.net/2027.42/99020>en_US
dc.identifier.issn0014-2980en_US
dc.identifier.issn1521-4141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/99020
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherA Kten_US
dc.subject.otherMacrophagesen_US
dc.subject.otherMEK 1/2en_US
dc.subject.otherSepsisen_US
dc.subject.otherCecal Ligation and Punctureen_US
dc.titleThe interaction between C 5a and both C 5a R and C 5 L 2 receptors is required for production of G ‐ CSF during acute inflammationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23575697en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/99020/1/eji2635.pdf
dc.identifier.doi10.1002/eji.201243075en_US
dc.identifier.sourceEuropean Journal of Immunologyen_US
dc.identifier.citedreferenceLajoie, S., Lewkowich, I. P., Suzuki, Y., Clark, J. R., Sproles, A. A., Dienger, K., Budelsky, A. L. et al., Complement‐mediated regulation of the IL ‐17 A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 2010. 11: 928 – 935.en_US
dc.identifier.citedreferenceCain, S. A. and Monk, P. N., The orphan receptor C 5 L 2 has high affinity binding sites for complement fragments C 5a and C 5a des‐ A rg(74). J. Biol. Chem. 2002. 277: 7165 – 7169.en_US
dc.identifier.citedreferenceRittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber‐Lang, M., Mackay, C. R., Zetoune, F. S. et al., Functional roles for C 5a receptors in sepsis. Nat. Med. 2008. 14: 551 – 557.en_US
dc.identifier.citedreferenceHuber‐Lang, M., Sarma, J. V., Rittirsch, D., Schreiber, H., Weiss, M., Flierl, M., Younkin, E. et al., Changes in the novel orphan, C 5a receptor ( C 5 L 2), during experimental sepsis and sepsis in humans. J. Immunol. 2005. 174: 1104 – 1110.en_US
dc.identifier.citedreferenceZhang, X., Schmudde, I., Laumonnier, Y., Pandey, M. K., Clark, J. R., Konig, P., Gerard, N. P. et al., A critical role for C 5 L 2 in the pathogenesis of experimental allergic asthma. J. Immunol. 2010. 185: 6741 – 6752.en_US
dc.identifier.citedreferenceZheng, Y. Y., Xie, X., Ma, Y. T., Yang, Y. N., Fu, Z. Y., Li, X. M., Ma, X. et al., Relationship between a novel polymorphism of the C 5 L 2 gene and coronary artery disease. PLoS One 2011. 6: e20984.en_US
dc.identifier.citedreferenceBosmann, M., Patel, V. R., Russkamp, N. F., Pache, F., Zetoune, F. S., Sarma, J. V. and Ward, P. A., M y D 88‐dependent production of IL ‐17 F is modulated by the anaphylatoxin C 5a via the A kt signaling pathway. FASEB J. 2011. 25: 4222 – 4232.en_US
dc.identifier.citedreferenceBosmann, M., Sarma, J. V., Atefi, G., Zetoune, F. S. and Ward, P. A., Evidence for anti‐inflammatory effects of C 5a on the innate IL ‐17 A / IL ‐23 axis. FASEB J. 2012. 26: 1640 – 1651.en_US
dc.identifier.citedreferenceHawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C. and Kohl, J., C 5a negatively regulates toll‐like receptor 4‐induced immune responses. Immunity 2005. 22: 415 – 426.en_US
dc.identifier.citedreferenceWittmann, M., Zwirner, J., Larsson, V. A., Kirchhoff, K., Begemann, G., Kapp, A., Gotze, O. et al., C 5a suppresses the production of IL ‐12 by IFN ‐gamma‐primed and lipopolysaccharide‐challenged human monocytes. J. Immunol. 1999. 162: 6763 – 6769.en_US
dc.identifier.citedreferenceRiedemann, N. C., Guo, R. F., Sarma, V. J., Laudes, I. J., Huber‐Lang, M., Warner, R. L., Albrecht, E. A. et al., Expression and function of the C 5a receptor in rat alveolar epithelial cells. J. Immunol. 2002. 168: 1919 – 1925.en_US
dc.identifier.citedreferenceLaudes, I. J., Chu, J. C., Huber‐Lang, M., Guo, R. F., Riedemann, N. C., Sarma, J. V., Mahdi, F. et al., Expression and function of C 5a receptor in mouse microvascular endothelial cells. J. Immunol. 2002. 169: 5962 – 5970.en_US
dc.identifier.citedreferenceRiedemann, N. C., Guo, R. F., Hollmann, T. J., Gao, H., Neff, T. A., Reuben, J. S., Speyer, C. L. et al., Regulatory role of C 5a in LPS ‐induced IL ‐6 production by neutrophils during sepsis. FASEB J. 2004. 18: 370 – 372.en_US
dc.identifier.citedreferenceBosmann, M., Grailer, J. J., Zhu, K., Matthay, M. A., Sarma, J. V., Zetoune, F. S. and Ward, P. A., Anti‐inflammatory effects of beta2 adrenergic receptor agonists in experimental acute lung injury. FASEB J. 2012. 26: 2137 – 2144.en_US
dc.identifier.citedreferenceChen, N. J., Mirtsos, C., Suh, D., Lu, Y. C., Lin, W. J., McKerlie, C., Lee, T. et al., C 5 L 2 is critical for the biological activities of the anaphylatoxins C 5a and C 3a. Nature 2007. 446: 203 – 207.en_US
dc.identifier.citedreferenceStrainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., Shapiro, V. S. et al., Locally produced complement fragments C 5a and C 3a provide both costimulatory and survival signals to naive CD 4+ T cells. Immunity 2008. 28: 425 – 435.en_US
dc.identifier.citedreferenceZhang, X., Kimura, Y., Fang, C., Zhou, L., Sfyroera, G., Lambris, J. D., Wetsel, R. A. et al., Regulation of T oll‐like receptor‐mediated inflammatory response by complement in vivo. Blood 2007. 110: 228 – 236.en_US
dc.identifier.citedreferenceBamberg, C. E., Mackay, C. R., Lee, H., Zahra, D., Jackson, J., Lim, Y. S., Whitfeld, P. L. et al., The C 5a receptor ( C 5a R ) C 5 L 2 is a modulator of C 5a R ‐mediated signal transduction. J. Biol. Chem. 2010. 285: 7633 – 7644.en_US
dc.identifier.citedreferenceLee, H. M., Wu, W., Wysoczynski, M., Liu, R., Zuba‐Surma, E. K., Kucia, M., Ratajczak, J. et al., Impaired mobilization of hematopoietic stem/progenitor cells in C 5‐deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 2009. 23: 2052 – 2062.en_US
dc.identifier.citedreferenceJalili, A., Shirvaikar, N., Marquez‐Curtis, L., Qiu, Y., Korol, C., Lee, H., Turner, A. R. et al., Fifth complement cascade protein ( C 5) cleavage fragments disrupt the SDF ‐1/ CXCR 4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Exp. Hematol. 2010. 38: 321 – 332.en_US
dc.identifier.citedreferenceKourtzelis, I., Markiewski, M. M., Doumas, M., Rafail, S., Kambas, K., Mitroulis, I., Panagoutsos, S. et al., Complement anaphylatoxin C 5a contributes to hemodialysis‐associated thrombosis. Blood 2010. 116: 631 – 639.en_US
dc.identifier.citedreferenceHopken, U. E., Lu, B., Gerard, N. P. and Gerard, C., The C 5a chemoattractant receptor mediates mucosal defence to infection. Nature 1996. 383: 86 – 89.en_US
dc.identifier.citedreferenceGerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S. and Gerard, C., An anti‐inflammatory function for the complement anaphylatoxin C 5a‐binding protein, C 5 L 2. J. Biol. Chem. 2005. 280: 39677 – 39680.en_US
dc.identifier.citedreferenceBosmann, M., Russkamp, N. F., Patel, V. R., Zetoune, F. S., Sarma, J. V. and Ward, P. A., The outcome of polymicrobial sepsis is independent of T and B cells. Shock 2011. 36: 396 – 401.en_US
dc.identifier.citedreferenceBosmann, M. and Ward, P. A., Role of C 3, C 5 and anaphylatoxin receptors in acute lung injury and in sepsis. Adv. Exp. Med. Biol. 2012. 946: 147 – 159.en_US
dc.identifier.citedreferenceGerard, C. and Gerard, N. P., C 5 A anaphylatoxin and its seven transmembrane‐segment receptor. Annu. Rev. Immunol. 1994. 12: 775 – 808.en_US
dc.identifier.citedreferenceGerard, N. P. and Gerard, C., The chemotactic receptor for human C 5a anaphylatoxin. Nature 1991. 349: 614 – 617.en_US
dc.identifier.citedreferenceWetsel, R. A., Expression of the complement C 5a anaphylatoxin receptor ( C 5a R ) on non‐myeloid cells. Immunol. Lett. 1995. 44: 183 – 187.en_US
dc.identifier.citedreferenceBosmann, M., Haggadone, M. D., Hemmila, M. R., Zetoune, F. S., Sarma, J. V. and Ward, P. A., Complement activation product C 5a is a selective suppressor of TLR 4‐induced, but not TLR 3‐induced, production of IL ‐27(p28) from macrophages. J. Immunol. 2012. 188: 5086 – 5093.en_US
dc.identifier.citedreferenceLalli, P. N., Strainic, M. G., Yang, M., Lin, F., Medof, M. E. and Heeger, P. S., Locally produced C 5a binds to T cell‐expressed C 5a R to enhance effector T ‐cell expansion by limiting antigen‐induced apoptosis. Blood 2008. 112: 1759 – 1766.en_US
dc.identifier.citedreferenceRicklin, D., Hajishengallis, G., Yang, K. and Lambris, J. D., Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010. 11: 785 – 797.en_US
dc.identifier.citedreferenceOkinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M. et al., C 5 L 2, a nonsignaling C 5 A binding protein. Biochemistry 2003. 42: 9406 – 9415.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
eji2635.pdf
Size:
488.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.